scispace - formally typeset
W

Wiley A. Schell

Researcher at Duke University

Publications -  93
Citations -  6326

Wiley A. Schell is an academic researcher from Duke University. The author has contributed to research in topics: Candida albicans & Cryptococcus neoformans. The author has an hindex of 41, co-authored 91 publications receiving 5826 citations. Previous affiliations of Wiley A. Schell include Research Triangle Park & Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease

TL;DR: Hsp90 provides a much-needed strategy for improving the treatment of fungal disease because it enhances the efficacy of existing antifungals, blocks the emergence of drug resistance, and exerts broad-spectrum activity against diverse fungal pathogens.
Journal ArticleDOI

Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.

TL;DR: It is demonstrated that Hsp90 governs cellular circuitry required for resistance to the only new class of antifungals to reach the clinic in decades, the echinocandins, which inhibit biosynthesis of a critical component of the fungal cell wall.
Journal ArticleDOI

Multiplexed Real-Time Polymerase Chain Reaction on a Digital Microfluidic Platform

TL;DR: A versatile digital microfluidic platform for multiplexed real-time polymerase chain reactions (PCR) that reliably detected diagnostic DNA levels of methicillin-resistant Staphylococcus aureus, Mycoplasma pneumoniae, and Candida albicans and was consistently repeatable across multiple PCR loops both within and between cartridges.
Journal ArticleDOI

PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90

TL;DR: A new role for PKC signaling in drug resistance, novel circuitry through which Hsp90 regulates drug resistance is established, and that targeting stress response signaling provides a promising strategy for treating life-threatening fungal infections are established.
Journal ArticleDOI

The New Fungal Opportunists Are Coming

TL;DR: This discussion addresses several issues of pathogenesis, epidemiology, diagnosis, and treatment with regard to these new opportunists, through a review of both general and specific concepts.